GENERAL ATLANTIC, L.P. filings

This page lists the SEC filings reported by GENERAL ATLANTIC, L.P..

SEC filings by GENERAL ATLANTIC, L.P. (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2023-06-23GENERAL ATLANTIC, L.P.Pharvaris N.V.4,406,25210.8%EDGAR
SC 13D/A2023-06-15GENERAL ATLANTIC, L.P.Immunocore Holdings plc2,855,8975.9%EDGAR
SC 13D/A2023-06-09GENERAL ATLANTIC, L.P.XP Inc.29,617,7337.1%EDGAR
SC 13G/A2023-05-02GENERAL ATLANTIC, L.P.Oak Street Health, Inc.00.0%EDGAR
SC 13D/A2023-05-01GENERAL ATLANTIC, L.P.Arco Platform Ltd.5,827,50414.5%EDGAR
SC 13D/A2023-04-25GENERAL ATLANTIC, L.P.dLocal Ltd63,096,50138.9%EDGAR
SC 13D/A2023-04-19GENERAL ATLANTIC, L.P.China Index Holdings Ltd00.0%EDGAR
SC 13D/A2023-03-31GENERAL ATLANTIC, L.P.Arco Platform Ltd.5,827,50414.5%EDGAR
SC 13D2023-03-23GENERAL ATLANTIC, L.P.dLocal Ltd61,300,35037.9%EDGAR
SC 13D/A2023-02-28GENERAL ATLANTIC, L.P.CinCor Pharma, Inc.00.0%EDGAR
SC 13G/A2023-02-14GENERAL ATLANTIC, L.P.Clear Secure, Inc.11,394,01212.7%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Alignment Healthcare, Inc.60,993,32332.6%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.dLocal Ltd57,660,76635.6%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Duolingo, Inc.1,479,2944.7%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.European Wax Center, Inc.22,817,20141.5%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Ginkgo Bioworks Holdings, Inc.32,319,8962.4%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Oak Street Health, Inc.61,384,47525.3%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Royalty Pharma plc26,244,7415.6%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Samsara Inc.9,227,0206.9%EDGAR
SC 13G/A2023-02-13GENERAL ATLANTIC, L.P.Sonendo, Inc.00.0%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.